The FDA has approved Widaplik, a polypill combining telmisartan, amlodipine, and indapamide, for the treatment of ...

The health secretary fired all the members of the Advisory Committee on Immunization Practices late on Monday.

Office of Prescription Drug Promotion (“OPDP”) posted a warning letter (the “Letter”)[1], issued on May 29, 2025, to Sprout ...

The fund outperformed the benchmark during the last quarter. From a sector perspective, Energy was at the forefront of index returns as global oil prices rallied.

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

Since McKinney Health burst onto the scene in 2022, it has been carving out its place at the intersection of health and life.